| Current Price | $42.41 | Mkt Cap | $2.8B |
|---|---|---|---|
| Open | $41.87 | P/E Ratio | -15.07 |
| Prev. Close | $42.41 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $41.84 - $43.02 | Volume | 163,437 |
| 52-Wk Range | $36.17 - $58.67 | Avg. Daily Vol. | 258,713 |
| Current Price | $42.41 | Mkt Cap | $2.8B |
|---|---|---|---|
| Open | $41.87 | P/E Ratio | -15.07 |
| Prev. Close | $42.41 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $41.84 - $43.02 | Volume | 163,437 |
| 52-Wk Range | $36.17 - $58.67 | Avg. Daily Vol. | 258,713 |
The best Bull and Bear pitches based on recency and number of recommendations.
There are no pitches that meet the Top Bear criteria. Explain
If this upsets you, start recommending pitches below!
Read the most recent pitches from players about GLPG.
Recs
ptgrasshopper
(< 20)
Submitted: 7/23/2018 11:50:12 PM :
Start Price:
$108.69
NASDAQ:GLPG Score:
-112.55
Large pipeline .
Recs
TMFEBCapital
(71.71)
Submitted: 4/6/2018 12:43:43 PM :
Start Price:
$95.78
NASDAQ:GLPG Score:
-118.17
Top-line data from its first RA trial with Gilead is anticipated in the second-half of 2018. Data from its triplet in cystic fibrosis with AbbVie is also on tap soon.
Recs
Omnius78
(< 20)
Submitted: 7/14/2016 1:23:28 PM :
Start Price:
$53.44
NASDAQ:GLPG Score:
-118.65
Huge potential when Filgotinib gets approved.
Find the members with the highest scoring picks in GLPG.
TrackStifel (< 20) Score: +150.77
The Score Leader is the player with the highest score across all their picks in GLPG.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| TheMyF | < 20 | 8/23/2021 |
|
5Y | $56.35 | -24.74% | -4.06% | -20.68 | 0 Comment | |
| SalteestOcean | < 20 | 5/12/2021 |
|
1Y | $71.79 | -40.92% | +3.86% | -44.78 | 0 Comment | |
| TMFang4apples | 29.15 | 2/22/2021 |
|
NS | $85.92 | -50.64% | +9.86% | -60.50 | 0 Comment | |
| soypollo | 29.77 | 2/8/2021 |
|
5Y | $106.14 | -60.04% | +9.72% | -69.76 | 0 Comment | |
| RonaldSpeth1 | 57.33 | 4/27/2016 |
|
5Y | $45.21 | -6.19% | +105.15% | -111.34 | 0 Comment | |
| StockPicker1959 | < 20 | 7/1/2019 |
|
5Y | $130.14 | -67.41% | +43.96% | -111.37 | 0 Comment | |
| portefeuille7 | 84.18 | 12/19/2017 |
|
5Y | $90.19 | -52.98% | +59.08% | -112.06 | 0 Comment | |
| portefeuille8 | 94.47 | 12/19/2017 |
|
5Y | $90.19 | -52.98% | +59.08% | -112.06 | 0 Comment | |
| ptgrasshopper | < 20 | 7/24/2018 |
|
5Y | $108.69 | -60.98% | +51.57% | -112.55 | 1 Comment | |
| gfischer | 29.62 | 7/23/2018 |
|
3Y | $107.48 | -60.54% | +52.84% | -113.38 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
